1200498-40-3

Basic information

• Product Name: Methyl 5-chloro-3-fluoropyridine-2-carboxylate
• Synonyms: Methyl 5-chloro-3-fluoropyridine-2-carboxylate;Methyl 5-chloro-3-fluoropicolinate;Methyl 5-chloro-3-fluoropicolinate, 5-Chloro-3-fluoro-2-(methoxycarbonyl)pyridine;5-Chloro-3-fluoro-pyridine-2-carboxylic acid methyl ester
• CAS NO: 1200498-40-3
• Molecular Formula: C7H5ClFNO2
• Molecular Weight: 189.5715032
• Mol File: 1200498-40-3.mol
• Article Data: 5

Chemical Properties

• Appearance: /
• CAS DataBase Reference: Methyl 5-chloro-3-fluoropyridine-2-carboxylate(CAS DataBase Reference)
• NIST Chemistry Reference: Methyl 5-chloro-3-fluoropyridine-2-carboxylate(1200498-40-3)
• EPA Substance Registry System: Methyl 5-chloro-3-fluoropyridine-2-carboxylate(1200498-40-3)

Safety Data

• Hazardous Substances Data: 1200498-40-3(Hazardous Substances Data)

Usage

General Description

Methyl 5-chloro-3-fluoropyridine-2-carboxylate is a chemical compound with the molecular formula C7H5ClFNO2. It is a pyridine derivative with a methyl ester group attached to the carboxylate. Methyl 5-chloro-3-fluoropyridine-2-carboxylate is commonly used in the pharmaceutical and agrochemical industries as an intermediate for the synthesis of various biologically active compounds and agricultural chemicals. It is known for its potential as a building block in the development of new drugs and pesticides. Methyl 5-chloro-3-fluoropyridine-2-carboxylate is also used in the research and development of novel molecules for various applications.

Upstream product

• 67-56-1 methanol 
• 1200498-38-9 C₆H₂ClFNO₂^(1-)*Li⁽¹⁺⁾ 
• 514797-96-7 5-chloro-3-fluoropyridin-2-ol 
• 514797-97-8 2-bromo-5-chloro-3-fluoro-pyridine 
• 89402-43-7 5-chloro-2,3-difluoropyridine 
• 207994-08-9 5-chloro-3-fluoro-2-pyridinecarboxylic acid 
• 18107-18-1 diazomethyl-trimethyl-silane 

Downstream Products

• 1200498-46-9 5-cyano-3-fluoropyridine-2-carboxylic acid 
• 214055-12-6 (5-chloro-3-fluoropyridin-2-yl)methanol 

Relevant articles and documents

NOVEL GALACTOSIDE INHIBITOR OF GALECTINS

The present invention relates to a compound of the general formula (I) wherein the pyranose ring is a-D-galactopyranose, R1 is selected from the group consisting of (II) wherein the asterix 1 * indicates the carbon atom of the heteroaromatic ring that is covalently attached to the triazole group of formula (I). The compound of formula (I) is suitable for use in a method for treating a disorder relating to the binding of a galectin, such as galectin-1 to a ligand in a mammal, such as a human.

TRICYCLIC PIPERIDINE COMPOUNDS

The present invention relates to compounds of the formula (I), wherein R, R1a, R1b, R2, R3, and X are as described in the description, to their preparation, to pharmaceutically acceptable salts thereof, and to their use as pharmaceuticals, to pharmaceutical compositions containing one or more compounds of formula (I), to methods for the preparation of such compounds of formula (I), and especially to their use as TPH modulators.

SULFUR-CONTAINING HETEROCYCLIC DERIVATIVE HAVING ?-SECRETASE-INHIBITING ACTIVITY

The following compound is provided as an agent for treating a disease induced by production, secretion and/or deposition of amyloid β protein, for example,. a compound represented by the formula (I): wherein ruing A is an optionally substituted carbocyclic group or an optionally substituted heterocyclic group, R1 is optionally substituted lower alkyl or the like, R2a and R2b are each independently hydrogen, optionally substituted lower alkyl or the like, R3a and R3c are each independently hydrogen, halogen, hydroxy, optionally substituted lower alkyl or the like, or a pharmaceutically acceptable salt thereof, or a solvate thereof.